Ytiliga

Delhi, India Founded: 2016 • Age: 10 yrs
Ytiliga develops, manufactures, and distributes specialty pharmaceutical drugs internationally.
Annual revenue $105,555 Latest available
Total funding - Funding intelligence
Employees 14 Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Ytiliga

Ytiliga is a company based in Delhi (India) founded in 2016. It operates as a B2B. The company has 14 employees as of March 31, 2023. Ytiliga offers products and services including UroTron™, NephroTron™, AndroXprts™, and CNStron™. Ytiliga operates in a competitive market with competitors including McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.

  • Headquarter Delhi, India
  • Employees 14 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ytiliga Private Limited
  • Date of Incorporation 09 May, 2016
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $105.55 K (USD)
    55.27
    as on Mar 31, 2023
  • Net Profit
    $3.52 K (USD)
    615.85
    as on Mar 31, 2023
  • EBITDA
    $5.4 K (USD)
    -55.36
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    14

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ytiliga

Ytiliga offers a comprehensive portfolio of products and services, including UroTron™, NephroTron™, AndroXprts™, and CNStron™.

Product name locked
Category locked
Primary

Specialty drug for treating urological conditions effectively.

Product name locked
Category locked
Locked

Medication for managing kidney-related disorders promptly.

Product name locked
Category locked
Locked

Products focused on male reproductive health solutions.

Product name locked
Category locked
Locked

Drugs for various targeted medical conditions worldwide.

Funding Insights of Ytiliga

Premium access

Detailed funding history for Ytiliga

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ytiliga

Investments
Premium access

Investment portfolio details for Ytiliga

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ytiliga

Premium access

Detailed financials for Ytiliga

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ytiliga Comparisons

Ytiliga Primary company
Description
Ytiliga develops, manufactures, and distributes specialty ph...
Location
Delhi, India
Founded Year
2016
Annual Revenue
$105.55 K (USD)
Net Profit
$3.52 K (USD)
EBITDA
$5.4 K (USD)
Employees
14
As of 2023
Premium access

Peer comparison for Ytiliga

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ytiliga

Ytiliga operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Products and services are provided in the healthcare industry.
Locked Locked Locked
Supply chain services for biopharma sector are provided.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Compound management solutions are offered for drug discovery processes.
Locked Locked Locked
AI-based logistics services are provided in Hangzhou, China.
Locked Locked Locked
Life sciences and supply chain management services are provided.
Premium access

Detailed competitors of Ytiliga

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ytiliga

Premium access

Complete news archive for Ytiliga

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ytiliga

Ytiliga was founded in 2016.

Ytiliga is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

As of Mar 31, 2023, the latest employee count at Ytiliga is 14.

Annual revenue of Ytiliga is $105.55K as on Mar 31, 2023.

Ytiliga Private Limited, founded in 2016 in Delhi, India, is a pharmaceutical company focused on research and innovation in healthcare. It produces high-quality drugs for specialties like gynaecology, urology, and nephrology, emphasizing agility and excellence. The company operates globally, offering affordable solutions through divisions such as UroTron and NephroTron, while prioritizing patient-centric approaches and intellectual property protection.

Ytiliga's top competitors include Entero Healthcare, McKesson and Resilience.

Ytiliga offers UroTron™, NephroTron™, AndroXprts™, and CNStron™.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available